Shehzad Basaria
Brigham and Women's Hospital · Boston University · Johns Hopkins University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Shehzad Basaria as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:22 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04895306 · Testosterone Replacement to Alleviate Pain in Postmenopausal Women (TRAPP Trial)Brigham and Women's Hospital · completed · Pain, Opioid Use, Androgen Deficiency · principal investigator
- Ph2NCT04798469 · Pain Alleviation With Testosterone in Opioid-Induced HypogonadismBrigham and Women's Hospital · recruiting · Opioid Use, Pain, Hypogonadism, Male · principal investigator
- N/ANCT04485767 · RESIST-ADT (Androgen Deprivation Therapy)Dana-Farber Cancer Institute · completed · Prostate Cancer, Physical Function · principal investigator
- N/ANCT00494208 · TDSM- Testosterone Dose Response in Surgically Menopausal WomenEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · completed · Hysterectomy, Ovariectomy, Menopause · study director
- Ph2NCT00351819 · Effects of Testosterone Replacement on Pain Sensitivity and Pain PerceptionBoston University · completed · Pain, Hypogonadism · principal investigator
- Ph4NCT00245518 · Effect of Soy on Cognition and Hot Flashes in Men With Prostate Cancer Undergoing Testosterone Suppression TherapyJohns Hopkins University · completed · Hot Flashes · principal investigator
- Ph4NCT00240981 · TOM: Testosterone in Older Men With SarcopeniaBoston Medical Center · terminated · Sarcopenia, Hypogonadism, Muscular Diseases · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:22 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Androgen Replacement to Improve Patient-Important Outcomes in Men with Opioid-Induced HypogonadismR01AG066921 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2020 to 2026 · $808,444 awarded in 2026Same name and institution; not confirmed by an ID
- Mentoring in Endocrine and Cardiometabolic Abnormalities in Cancer and AgingK24AG070078 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2021 to 2025 · $185,485 awarded in 2025Same name and institution; not confirmed by an ID
- Exploring the Role of Testosterone as a Novel Anti-Nociceptive Agent in Women with Chronic Pain and Opioid UseR21AG071907 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2021 to 2022 · $223,750 awarded in 2022Same name and institution; not confirmed by an ID
- Preventing a Decline in Physical Function in Older Androgen-Deprived Men with Structured Exercise TrainingR21AG065537 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2020 to 2021 · $230,274 awarded in 2021Grant number is on one of their registry trials
- Gaining Metabolic Insight in Older Men undergoing Androgen Deprivation Therapy for Prostate CancerR01CA226211 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2018 to 2020 · $416,443 awarded in 2020Same name and institution; not confirmed by an ID
- Hypogonadism and Pain Perception in Androgen-Deprived Men with Prostate CancerR21CA171316 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2013 to 2014 · $191,059 awarded in 2014Same name and institution; not confirmed by an ID
- ISOFLAVONES IN PROSTATE CANCER UNDERGOING ANDROGEN DEPRIVATION THERAPYM01RR000052 · NCRR · JOHNS HOPKINS UNIVERSITY · fiscal years 2006 to 2007 · $1,201 awarded in 2007Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- TESTOSTERONE SUPPLEMENTATION FOR MEN WITH SARCOPENIAU01AG014369 · NIA · BOSTON MEDICAL CENTER · PI SHALENDER BHASIN · fiscal years 2005 to 2011Named on NCT00240981
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:22 UTC. The ranking covers the 200 most relevant of 62 PubMed records, and a shared surname and initials can bring in a namesake. All 62 on PubMed
- Adverse events associated with testosterone administration.N Engl J Med · 20101,119 citationsRCR 34.6
- Effects of Testosterone Treatment in Older Men.N Engl J Med · 2016652 citationsRCR 29.7
- Cardiovascular Safety of Testosterone-Replacement Therapy.N Engl J Med · 2023367 citationsRCR 48.7
- Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point.J Gerontol A Biol Sci Med Sci · 2014313 citationsRCR 12.9
- Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone.JAMA · 2017299 citationsRCR 12.8
- Effect of Testosterone Treatment on Volumetric Bone Density and Strength in Older Men With Low Testosterone: A Controlled Clinical Trial.JAMA Intern Med · 2017247 citationsRCR 11.5
- Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer.J Clin Endocrinol Metab · 2004201 citationsRCR 5.2
- 199 citationsRCR 8.3
- A Randomized Trial of a Multifactorial Strategy to Prevent Serious Fall Injuries.N Engl J Med · 2020198 citationsRCR 13.2
- Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis.J Clin Endocrinol Metab · 2010188 citationsRCR 6.2